DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)

DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI) is a COMPANY registered in GENEVA, Switzerland and holds an LEI in its own name.

The LEI has been on record for 10 years, since 28 Jun 2016. That is about 2 years earlier than the median LEI in Switzerland, which dates from 2018 — an early adopter by local standards.

Annual re-validation is 2963 days overdue: it fell due 28 Jun 2018. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with UID-Register under registry number CHE-110.141.200, and the LEI itself is issued and maintained by LONDON STOCK EXCHANGE LEI LIMITED, one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.